Regulatory ApprovalFormycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® 25.02.2025 / 06:30 CET/CESTThe issuer is solely ...
WHY EUROPE MUST ACT TO PROTECT ACCESS TO MEDICINESAmsterdam, 20 February 2025 New research by Teva Pharmaceuticals Europe shows that 46% of generic medicines from the EU Critical List of Medicines are ...
The Sound Shore Fund Investor Class (SSHFX) and Institutional Class (SSHVX) advanced 1.25% and 1.32%, respectively, in Q3 ...
National healthcare leader PAM Health has announced plans to build a 42-bed physical medicine and rehabilitation hospital in Minneola, Florida. The new hospital will create approximately 80 new jobs ...
The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting ...
Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve Worland, Ph.D. as Chief ...
Even with some selling after Friday’s jobs report, stocks are likely to close the week slightly higher. The question is, where are investor dollars moving? Sector rotation is underway, as ...
Hosted on MSN17d
MarketBeat Week in Review – 02/03 - 02/07Even with some selling after Friday's jobs report, stocks are likely ... a discount on their prescriptions, they turn to Teva Pharmaceuticals Industries Ltd. (NYSE: TEVA). The stock turned lower ...
In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...
In its fourth quarter 2024 investor letter, Sound Shore Management emphasized stocks such as Teva Pharmaceutical Industries Limited (NYSE:TEVA). Headquartered in Tel Aviv, Israel, Teva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback